NEOCLONE BIOTECHNOLOGY INTERNATIONAL

Basic Information

1202 Ann St
MADISON, WI, 53713-2410

Company Profile

n/a

Additional Details

Field Value
DUNS: 19933295
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Reactivation of human cells for novel fully human Ab platform

    Amount: $286,368.00

    DESCRIPTION (provided by applicant): Monoclonal antibodies (mAbs) have been developed into a highly effective class of therapeutic molecules, with global growth of 37% between 2001 and 2002. Since the ...

    SBIR Phase I 2012 Department of Health and Human Services
  2. Improving Ovarian Cancer Treatment by Targeting a Novel Epitope of MUC16

    Amount: $190,591.00

    DESCRIPTION (provided by applicant): The CA125 antigen is a well known marker for monitoring the recurrence and progression of epithelial ovarian cancer. It is now clear that this antigen is a repeati ...

    STTR Phase I 2009 Department of Health and Human Services
  3. BIOMARKER SCREENING WITH REVOLUTIONARY NEOABS

    Amount: $206,777.00

    Not Available

    SBIR Phase II 2008 Department of Health and Human Services
  4. BIOMARKER SCREENING WITH REVOLUTIONARY NEOABS

    Amount: $507,208.00

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  5. Novel Platform Technology for Developing Therapeutic Human mAbs

    Amount: $140,000.00

    DESCRIPTION (provided by applicant): Despite significant advances in treatment and early detection, cancer remains a significant disease threat to society. Therapeutic monoclonal antibodies are effect ...

    SBIR Phase I 2007 Department of Health and Human Services
  6. A novel platform for mining the repertoire of antigen-specific B cells

    Amount: $99,635.00

    DESCRIPTION (provided by applicant): Cancer remains a significant threat to the health and economy of today's society. Advances in cancer research are key to cancer biomarker discovery, develop ...

    SBIR Phase I 2007 Department of Health and Human Services
  7. BIOMARKER SCREENING WITH REVOLUTIONARY NEOABS

    Amount: $507,208.00

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  8. BIOMARK SCRN W REVOLUTIONARY NEOAB ANTIBODIES

    Amount: $100,000.00

    N/A

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government